
Privia Health Group, Inc.: updates and filings
Price
$24.99
November 17, 2026Market cap $3.1B
What Ploutos Investor adds for Privia Health
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 5, 2026next Feb 5, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
May 2026
February 2026
December 2025
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operationsForm8-K
- Oct 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Oct 7, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Sep 8, 2026Over-5% holder statement (active)FormSCHEDULE 13D
- Aug 18, 2026Officer or director changeForm8-K
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operationsForm8-K
- Jul 29, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 7, 2026Officer or director changeForm8-K
- May 22, 2026Shareholder voteForm8-K
- May 7, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 7, 2026Results of operationsForm8-K
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 2, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 2, 2026Additional annual meeting materialFormDEFA14A
- Apr 2, 2026Annual meeting proxy statementFormDEF 14A
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 27, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 26, 2026Results of operationsForm8-K
- Dec 8, 2025Other material eventsForm8-K
- Nov 6, 2025Shelf registration for future offeringsFormS-3ASR
- Nov 6, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
- Nov 6, 2025Results of operationsForm8-K
- Nov 5, 2025Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations | Document |
| Oct 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Oct 7, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Sep 8, 2026 | SCHEDULE 13D | Over-5% holder statement (active) | Document |
| Aug 18, 2026 | 8-K | Officer or director change | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations | Document |
| Jul 29, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 7, 2026 | 8-K | Officer or director change | Document |
| May 22, 2026 | 8-K | Shareholder vote | Document |
| May 7, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 7, 2026 | 8-K | Results of operations | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 2, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 2, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 2, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 27, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 26, 2026 | 8-K | Results of operations | Document |
| Dec 8, 2025 | 8-K | Other material events | Document |
| Nov 6, 2025 | S-3ASR | Shelf registration for future offerings | Document |
| Nov 6, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
| Nov 6, 2025 | 8-K | Results of operations | Document |
| Nov 5, 2025 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 13, 2019.
The full analysis
What do Privia Health's filings show?
The filings are where every one of Privia Health's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.